Clinical Trials Browser

INDUSTRY × Arsenic Trioxide × Other hematologic neoplasm × Clear all

Leukemia, Leukemia, Promyelocytic, Acute

NCT06882031 2025-11-18

Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia

Phase 1 Completed

12 enrolled

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT04996030 2024-01-23

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

Phase 1 Suspended

16 enrolled

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00020969 2020-10-05

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Phase 2 Terminated

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00513305 2012-08-01

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia

Phase 3 Terminated

67 enrolled 15 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

LATITUDE

Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia